Lattice Biologics completes private placement

On Feb. 16, cellular therapies and tissue engineering company Lattice Biologics Ltd. (TSX-V:LBL; OTCQB:LBLTF) raised C$131,652 ($100,490) through the sale of 658,260 units at C$0.20 in the third tran...